SOLV
Solventum Corporation
88.62
-1.46 (-1.62%)
52w low 62.38
94.16 high
82.6% of range
Financial Analysis
| (USD) | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Total Revenue | -- | 8.13B | 8.20B | 8.25B | 8.32B | |
| Cost of Revenue | -- | 3.44B | 3.50B | 3.66B | 3.87B | |
| Gross Profit | -- | 4.70B | 4.69B | 4.59B | 4.45B | |
| Operating Expenses | -- | 3.00B | 3.06B | 3.56B | 3.82B | |
| R&D | -- | 767.00M | 758.00M | 775.00M | 739.00M | |
| SG&A | -- | 2.23B | 2.30B | 2.78B | 3.08B | |
| Operating Income | -- | 1.69B | 1.64B | 1.04B | 632.00M | |
| EBITDA | -- | 2.27B | 2.23B | 1.53B | 2.55B | |
| Pretax Income | -- | 1.69B | 1.67B | 605.00M | 1.71B | |
| Income Tax | -- | 349.00M | 321.00M | 127.00M | 157.00M | |
| Net Income | -- | 1.34B | 1.35B | 479.00M | 1.56B | |
| EPS Diluted | -- | 7.78 | 7.79 | 2.76 | 8.88 | |
| Diluted Shares | -- | 172.70M | 172.71M | 173.70M | 175.30M |
Revenue CAGR
+0.8%
Net Income CAGR
+5.0%
EPS CAGR
+4.5%
FCF CAGR
--
Revenue YoY
+0.9%